UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature reviews. Rheumatology, ISSN 1759-4790, 06/2018, Volume 14, Issue 6, pp. 324 - 325
Journal Article
Autoimmunity reviews, ISSN 1568-9972, 06/2020, Volume 19, Issue 6, p. 102539
Life Sciences & Biomedicine | Immunology | Science & Technology | Betacoronavirus - pathogenicity | Coronavirus Infections - prevention & control | Hydroxychloroquine - therapeutic use | Rheumatic Diseases - drug therapy | Coronavirus Infections - drug therapy | Humans | Middle Aged | Pandemics - prevention & control | Pneumonia, Viral - drug therapy | Hydroxychloroquine - adverse effects | COVID-19 | Respiratory Distress Syndrome - prevention & control | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Aged, 80 and over | Respiratory Distress Syndrome - drug therapy | Interleukin-1 - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - adverse effects | Antimalarials - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Comorbidity | Azetidines - adverse effects | Betacoronavirus - drug effects | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Chloroquine - adverse effects | Azetidines - therapeutic use | Coronavirus Infections - virology | Sulfonamides - therapeutic use | Pneumonia, Viral - prevention & control | Sulfonamides - adverse effects | Aged | Rheumatologists | Pneumonia, Viral - virology | Physician's Role
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 12/2017, Volume 76, Issue 12, pp. e54 - e54
Journal Article
Nature reviews. Rheumatology, ISSN 1759-4790, 11/2020, Volume 16, Issue 11, pp. 645 - 660
Journal Article
Pharmacological research, ISSN 1043-6618, 09/2019, Volume 147, pp. 104340 - 104340
Journal Article
Arthritis & rheumatology (Hoboken, N.J.), ISSN 2326-5191, 02/2015, Volume 67, Issue 2, pp. 568 - 575
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Prevalence | Cross-Sectional Studies | Fibromyalgia - epidemiology | United States | Humans | Middle Aged | Male | Scotland - epidemiology | Fibromyalgia - classification | Fibromyalgia - diagnosis | Adult | Female | Surveys and Questionnaires | Aged | Retrospective Studies | Confidence intervals | Fibromyalgia | Pain | Classification | Index Medicus | Abridged Index Medicus
Journal Article
Journal of immunology research, ISSN 2314-8861, 1/2019, Volume 2019, pp. 8567364 - 11
Life Sciences & Biomedicine | Immunology | Science & Technology | Adaptive Immunity | Carcinogenesis - immunology | Epigenesis, Genetic | Humans | Carcinogenesis - genetics | Immunity, Innate | Lymphoma, B-Cell - genetics | Sjogren's Syndrome - virology | Dysbiosis - immunology | Microbiota | Animals | Dysbiosis - genetics | Lymphoma, B-Cell - microbiology | Female | Lymphoma, B-Cell - virology | Mice | Sjogren's Syndrome - genetics | Sjogren's Syndrome - microbiology | Transformation | Dysbacteriosis | Sjogren's syndrome | Disease | Pathogenesis | Epithelial cells | DNA damage | Viruses | Genomes | Infections | Cell activation | Microorganisms | Lymphocytes | DNA methylation | Search engines | Genetics | Tumorigenesis | Deoxyribonucleic acid--DNA | Inducers | Immune system | Phenotypes | Immune response | Cytokines | Salivary glands | Rheumatology | Salivary gland | Inflammation | Gene expression | Patients | Lymphoma | Scientific papers | Lymphocytes B | Epigenetics | Autoimmune diseases | Viral infections | B-cell lymphoma | Index Medicus
Journal Article
8.
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, ISSN 0392-856X, 03/2020, Volume 38, Issue 2, pp. 337 - 342
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Severe Acute Respiratory Syndrome - epidemiology | Pandemics | Cytokines - metabolism | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Infection Control | Severe Acute Respiratory Syndrome - immunology | China - epidemiology | Severe Acute Respiratory Syndrome - drug therapy | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Anti-Inflammatory Agents - therapeutic use | Betacoronavirus | Antirheumatic Agents - therapeutic use
Journal Article
International journal of rheumatic diseases, ISSN 1756-1841, 06/2019, Volume 22, Issue 6, pp. 995 - 1001
absenteeism | presenteeism | infliximab | ankylosing spondylitis | anti‐TNF treatments | healthcare resource utilization | health‐related quality of life | work productivity and activity impairment | golimumab | anti-TNF treatments | health-related quality of life | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Drug Costs | Tumor Necrosis Factor Inhibitors - economics | Prospective Studies | Humans | Work Performance - economics | Antibodies, Monoclonal - therapeutic use | Male | Absenteeism | Infliximab - therapeutic use | Recovery of Function | Time Factors | Efficiency | Adult | Antirheumatic Agents - economics | Female | Antirheumatic Agents - therapeutic use | Spondylitis, Ankylosing - drug therapy | Infliximab - economics | Treatment Outcome | Spondylitis, Ankylosing - physiopathology | Spondylitis, Ankylosing - economics | Tumor Necrosis Factor Inhibitors - therapeutic use | Presenteeism | Spondylitis, Ankylosing - diagnosis | Cost-Benefit Analysis | Quality of Life | Sick Leave | Antibodies, Monoclonal - economics | Medical care | Care and treatment | Infliximab | Analysis | Ankylosing spondylitis | Quality management | Productivity | Resource utilization | Rheumatic diseases | Arthritis | Tumor necrosis factor-α | Patients | Inflammatory diseases | Quality of life | Spondylitis | Monoclonal antibodies | Tumor necrosis factor-TNF | Index Medicus
Journal Article
BMC medicine, ISSN 1741-7015, 2014, Volume 12, Issue 1, pp. 47 - 47
Autoimmunity | Auto-inflammatory disease | Oxidized LDL | Atherosclerosis | Innate immunity | Inflammasome | β2-glycoprotein I | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Autoimmune Diseases - epidemiology | Immunity, Innate - immunology | Animals | Atherosclerosis - immunology | Autoimmunity - immunology | Humans | Autoimmune Diseases - immunology | Atherosclerosis - diagnosis | Autoimmune Diseases - diagnosis | Adaptive Immunity - immunology | Atherosclerosis - epidemiology | Medicine, Experimental | Medical research | Immune response | Immunotherapy | Lupus | Heart attacks | Free radicals | Cytokines | Cardiovascular disease | Dentistry | Cholesterol | Proteins | Rodents | Ligands | Autoimmune diseases | Pharmaceutical sciences | Immune system | Veins & arteries | Index Medicus
Journal Article
Arthritis care & research (2010), ISSN 2151-464X, 12/2017, Volume 69, Issue 12, pp. 1878 - 1886
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Predictive Value of Tests | Chronic Pain - diagnosis | Prevalence | Humans | Middle Aged | Male | Arthralgia - physiopathology | Arthralgia - epidemiology | Young Adult | Chronic Pain - epidemiology | Adult | Female | Odds Ratio | Child | Severity of Illness Index | Fibromyalgia - epidemiology | Terminology as Topic | Logistic Models | Arthralgia - diagnosis | Fibromyalgia - classification | Chronic Pain - classification | Fibromyalgia - diagnosis | Arthralgia - classification | Chronic Pain - physiopathology | Fibromyalgia - physiopathology | Pain Measurement | United Kingdom - epidemiology | Pain | Sleep | Mood | Womens health | Low back pain | Fibromyalgia | Fatigue | Population studies | Children | Index Medicus
Journal Article
Arthritis care & research (2010), ISSN 2151-464X, 06/2016, Volume 68, Issue 6, pp. 738 - 743
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Humans | Middle Aged | Male | Arthritis, Rheumatoid - complications | Hepatitis B - complications | Virus Activation - drug effects | Arthritis, Rheumatoid - drug therapy | Abatacept - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Antirheumatic Agents - therapeutic use | Intravenous administration | Chronic active hepatitis | Liver | Prophylaxis | Case reports | Lamivudine | Infections | Serology | Patients | Tenofovir | Hepatitis | Adefovir | Immunosuppression | Rheumatoid arthritis | Safety | Health risk assessment | Deoxyribonucleic acid--DNA | Hepatitis B | Index Medicus
Journal Article